BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30696724)

  • 21. Clinical implications of the innovations in the primary tumour and metastasis of the 8
    Rami-Porta R; Eberhardt WEE
    J Thorac Dis; 2018 Aug; 10(Suppl 22):S2682-S2685. PubMed ID: 30345105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
    Finkle JH; Penney BC; Pu Y
    Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor-node-metastasis classification of colorectal cancer and the 9th edition of the Japanese classification.
    Shida D; Boku N; Nakamura Y; Yoshida T; Tanabe T; Yasui K; Takashima A; Kanemitsu Y
    Cancer Med; 2021 Oct; 10(20):6937-6946. PubMed ID: 34587374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
    Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
    Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.
    Hattori A; Takamochi K; Oh S; Suzuki K
    Jpn J Clin Oncol; 2019 Jan; 49(1):3-11. PubMed ID: 30277521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis.
    Toffart AC; Duruisseaux M; Brichon PY; Pirvu A; Villa J; Selek L; Guillem P; Dumas I; Ferrer L; Levra MG; Moro-Sibilot D
    Ann Thorac Surg; 2018 Mar; 105(3):957-965. PubMed ID: 29397931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
    Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
    J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the 7th edition of the TNM classification for lung cancer at a single institution.
    Wang J; Wu N; Zheng Q; Feng Y; Yan S; Lv C; Li S; Wang Y; Yang Y
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1189-95. PubMed ID: 24676426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer.
    Gibson AJW; Li H; D'Silva A; Tudor RA; Elegbede AA; Otsuka SM; Bebb DG; Cheung WY
    Med Oncol; 2018 Aug; 35(9):117. PubMed ID: 30073425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete resection of the primary lesion improves survival of certain patients with stage IV non-small cell lung cancer.
    Chikaishi Y; Shinohara S; Kuwata T; Takenaka M; Oka S; Hirai A; Yoneda K; Kuroda K; Imanishi N; Ichiki Y; Tanaka F
    J Thorac Dis; 2017 Dec; 9(12):5278-5287. PubMed ID: 29312736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicted outcomes of subdividing M1-stage metastatic lung cancer based on the prognosis and the response to local consolidative therapy.
    Wang F; Gao J; Ren Y; Su H; She Y; Xie D; Chen C
    Ann Transl Med; 2021 Aug; 9(16):1293. PubMed ID: 34532430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.
    Shen H; Cao Y; Li X; Tan Y; Chen J; Yang Z; Kong Y; Yuan Y
    Medicine (Baltimore); 2016 May; 95(21):e3800. PubMed ID: 27227958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
    Yang J; Peng A; Wang B; Gusdon AM; Sun X; Jiang G; Zhang P
    Clin Exp Metastasis; 2019 Oct; 36(5):457-466. PubMed ID: 31420766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer.
    Tan F; Bi N; Zhang H; Li R; Wang Z; Duan J; Jiang F; Feng D; Zhang R; Bai J; Cao J; Mao N; Liang K; Yin S; Shen Y; Feng F; Zhao J; Gao Y; Mao Y; Xue Q; Gao S; He J
    Lung Cancer; 2022 Aug; 170():98-104. PubMed ID: 35749952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a Contralateral Tumor Nodule on Survival in Non-Small-Cell Lung Cancer.
    Morris ZS; Cannon DM; Morris BA; Bentzen SM; Kozak KR
    J Thorac Oncol; 2015 Nov; 10(11):1608-15. PubMed ID: 26317917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of different extrathoracic metastasis patterns in patients with M1c lung adenocarcinoma receiving immunotherapy.
    Hu F; Peng J; Mao X; Niu Y; Ma M; Zhao Y; Gu A; Jiang L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3171-3184. PubMed ID: 35882652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy.
    Kadono Y; Nohara T; Ueno S; Izumi K; Kitagawa Y; Konaka H; Mizokami A; Onozawa M; Hinotsu S; Akaza H; Namiki M
    World J Urol; 2016 Feb; 34(2):261-7. PubMed ID: 26047654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
    Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
    Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.